MICHELLE YOUNG: Open Payments
NPI 1588160121 · HAMPTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 66 payments from 18 companies in 2025. Trend: 2023 $3,171 · 2024 $4,729 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $448 |
| JAZZ PHARMACEUTICALS INC. | 7 | $177 |
| Axsome Therapeutics, Inc. | 8 | $148 |
| Merck Sharp & Dohme LLC | 5 | $126 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Insmed, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| Verona Pharma, Inc. | 2 | $33 |
Products named: FASENRA, XYWAV, AIRSUPRA, Sunosi, WINREVAIR, NUCALA, Arikayce, MOUNJARO.
Industry payments across SC — which companies pay providers there.
